Real-World NeuroModulate: Investigating Non-Invasive Brain Stimulation for Neuropsychiatric Disorders at TUM

Recruiting now

Conditions studied: Depressive Syndrom

In brief

In this study, patients diagnosed with a depressive syndrome and with a clinical indication for treatment will receive an acute course of transcranial magnetic stimulation (TMS). The treatment consists of 20 TMS sessions administered over a period of four weeks (five sessions per week). Magnetic resonance imaging (MRI) will be performed at four time points: prior to the start of treatment, after 10 treatment sessions, after completion of all 20 sessions, and at a three-month follow-up after the end of treatment. The MRI data will include different imaging modalities to assess treatment-related neurobiological changes. The primary objective is to investigate changes in neuroimaging markers over the course of TMS treatment and to examine their associations with clinical response and behavioral as well as clinical outcome measures. Another key goal of the study is the identification of markers allowing for early prediction of treatment response to TMS and, additionally, for the prediction of relapse at follow-up.

Key facts

Study ID

NCT07420322

Run by

Technical University of Munich

People needed

100

Starts

2024-08-15

Expected to finish

2026-08-15

Last updated by the study team

2026-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 years or older
• Clinical indication for non-invasive brain stimulation due to a depressive episode (e.g., unipolar or bipolar depression) or predominant depression-associated symptoms (e.g., negative symptoms in schizophrenia-spectrum disorders)
• Insufficient response to first-line treatments and/or patient preference for brain stimulation treatment
• Capacity and willingness to provide written informed consent

You may not qualify if…

• Acute suicidal risk
• Presence of a significant neurological disorder or condition, including:
• Increased intracranial pressure
• Space-occupying brain lesions
• History of cerebrovascular accident within the last 12 months
• Incidental structural brain abnormalities on MRI requiring further diagnostic clarification
• For TMS specifically:
• Non-removable ferromagnetic implants in or near the stimulation site (e.g., cochlear implants, implanted neurostimulators, metallic clips or nails)
• Other treatment-relevant ferromagnetic implants (e.g., cardiac pacemakers)

Where it is running

• University Hospital Technical University of Munich — München, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.